Starting from the aforementioned notion that the SRF−MKL1 activation mediated by A-type lamin and emerin activity is essential in cells resident on a stiff matrix, the significance of this alteration is exacerbated in osteosarcoma, a tumor arising in the bone, the stiffest tissue of our body. The gene discussed is EMD; the disease is osteosarcoma.